- Home
- LGND vs PRVA Comparison
LGND vs PRVA Comparison
Compare LGND & PRVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGND
- PRVA
- Stock Information
- Founded
- LGND 1987
- PRVA 2007
- Country
- LGND United States
- PRVA United States
- Employees
- LGND 68
- PRVA N/A
- Industry
- LGND Biotechnology: Pharmaceutical Preparations
- PRVA Retail: Computer Software & Peripheral Equipment
- Sector
- LGND Health Care
- PRVA Technology
- Exchange
- LGND Nasdaq
- PRVA Nasdaq
- Market Cap
- LGND 3.2B
- PRVA 2.8B
- IPO Year
- LGND 1992
- PRVA 2021
- Fundamental
- Price
- LGND $169.53
- PRVA $22.32
- Analyst Decision
- LGND Strong Buy
- PRVA Strong Buy
- Analyst Count
- LGND 8
- PRVA 14
- Target Price
- LGND $144.71
- PRVA $28.79
- AVG Volume (30 Days)
- LGND 139.7K
- PRVA 682.6K
- Earning Date
- LGND 08-05-2025
- PRVA 11-06-2025
- Dividend Yield
- LGND N/A
- PRVA N/A
- EPS Growth
- LGND N/A
- PRVA N/A
- EPS
- LGND N/A
- PRVA 0.11
- Revenue
- LGND $181,488,000.00
- PRVA $1,900,071,000.00
- Revenue This Year
- LGND $18.41
- PRVA $95.64
- Revenue Next Year
- LGND $18.87
- PRVA $10.27
- P/E Ratio
- LGND N/A
- PRVA $203.12
- Revenue Growth
- LGND 53.40
- PRVA 12.05
- 52 Week Low
- LGND $81.74
- PRVA $16.47
- 52 Week High
- LGND $129.90
- PRVA $26.09
- Technical
- Relative Strength Index (RSI)
- LGND 72.58
- PRVA 52.32
- Support Level
- LGND $161.82
- PRVA $22.02
- Resistance Level
- LGND $169.00
- PRVA $23.12
- Average True Range (ATR)
- LGND 3.90
- PRVA 0.52
- MACD
- LGND -0.81
- PRVA -0.14
- Stochastic Oscillator
- LGND 98.73
- PRVA 15.16
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
About PRVA Privia Health Group Inc.
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.